INS and Hepatic fibrosis: A reduction in hepatic fat content could potentially exert beneficial effects on e.g. hepatic inflammation and fibrosis, however, some retrospective studies have indicated an association between insulin therapy in diabetes and increased risk of hepatic fibrosis and hepatocellular cancer [21–23].